Breast Cancer
Showing NaN - NaN of 163
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan
- +3 more
-
Chandler, Arizona
- +226 more
Aug 11, 2022
Lung Cancer, Esophageal Cancer, Thoracic Cancer Trial in Saint Louis (Home-based cardiac rehabilitation)
Recruiting
- Lung Cancer
- +8 more
- Home-based cardiac rehabilitation
-
Saint Louis, MissouriWashington University School of Medicine
Aug 9, 2022
Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)
Active, not recruiting
- Breast Cancer
- +3 more
- Palbociclib
- +7 more
-
Saint Louis, Missouri
- +1 more
Jul 20, 2022
Breast Reconstruction, Breast Cancer Trial in Saint Louis, Columbus (Breast Reconstruction Education and Support Tool
Recruiting
- Breast Reconstruction
- Breast Cancer
- Breast Reconstruction Education and Support Tool (BREASTChoice)
- +2 more
-
Saint Louis, Missouri
- +1 more
Jul 18, 2022
Breast Cancer Trial in Saint Louis (Social Contact Reminder)
Completed
- Breast Cancer
- Social Contact Reminder
-
Saint Louis, MissouriWashington University School of Medicine
Jul 6, 2022
Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)
Active, not recruiting
- Breast Cancer
- therapeutic conventional surgery
- whole breast irradiation
-
Hot Springs, Arkansas
- +349 more
Jun 16, 2022
Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))
Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)
Active, not recruiting
- Breast Cancer
- Amcenestrant-matching placebo
- +5 more
-
Daphne, Alabama
- +299 more
May 5, 2022
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Circulating Tumor DNA for Early Treatment Response Assessment of
Recruiting
- Healthy Volunteer
- +12 more
-
Saint Louis, MissouriWashington University School of Medicine
Apr 4, 2022
Breast Cancer, Breast Cancer Female, Cancer of Breast Trial in Saint Louis (Bupivacaine, Gabapentin, Celecoxib)
Completed
- Breast Cancer
- +2 more
- Bupivacaine
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Mar 3, 2022
Breast Cancer Trial in United States (Trastuzumab, Paclitaxel, Trastuzumab emtansine)
Breast Carcinoma, Breast Cancer, Stage 0 Breast Cancer Trial in Saint Louis (External Beam Accelerated Partial Breast
Recruiting
- Breast Carcinoma
- +3 more
- External Beam Accelerated Partial Breast Irradiation
-
Saint Louis, MissouriWashington University School of Medicine
Mar 3, 2022
Breast Carcinoma, Breast Cancer Trial in Saint Louis (Three Fraction Accelerated Partial Breast Irradiation, Partial mastectomy)
Active, not recruiting
- Breast Carcinoma
- Breast Cancer
- Three Fraction Accelerated Partial Breast Irradiation
- Partial mastectomy
-
Saint Louis, MissouriWashington University School of Medicine
Mar 15, 2022
Breast Cancer, Breast Carcinoma, Malignant Tumor of Breast Trial in Saint Louis, Columbus (Mammaglobin-A DNA Vaccine, Optional
Recruiting
- Breast Cancer
- +2 more
- Mammaglobin-A DNA Vaccine
- Optional biopsy
-
Saint Louis, Missouri
- +1 more
Jan 26, 2022
Breast Cancer Trial in Canada, Puerto Rico, United States (pegfilgrastim, AC regimen, cyclophosphamide)
Active, not recruiting
- Breast Cancer
- pegfilgrastim
- +4 more
-
Anniston, Alabama
- +541 more
Jan 19, 2022
Breast Cancer Trial in Saint Louis (Alloderm RTU, Cortiva 1mm Allograft Dermis, Skin or nipple-sparing mastectomy)
Active, not recruiting
- Breast Cancer
- Alloderm RTU
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 5, 2022
Breast Cancer Trial in United States (Nivolumab, Ipilimumab, Nab-paclitaxel)
Active, not recruiting
- Breast Cancer
- Nivolumab
- +2 more
-
Los Angeles, California
- +7 more
Dec 2, 2021
Breast Cancer Trial in Worldwide (biological, drug, other)
Completed
- Breast Cancer
- ramucirumab (IMC-1121B)
- +2 more
-
Birmingham, Alabama
- +232 more
Nov 3, 2021
Breast Cancer Trial in Saint Louis (Diagnostic Imaging ( 6a-[18F]fluoro-17ß-estradiol (FES)))
Withdrawn
- Breast Cancer
- Diagnostic Imaging ( 6α-[18F]fluoro-17β-estradiol (FES))
-
Saint Louis, MissouriMallinckrodt Institute of Radiology
Oct 21, 2021